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ABSTRACT 
PURPOSE 
To determine if T1-weighted MR signal of the pancreas can be used to detect early CP. 
METHODS 
A retrospective analysis was performed on 51 suspected CP patients, who had both secretin 
enhanced magnetic resonance cholangiopancreatography (S-MRCP) and an intraductal secretin 
stimulation test (IDST). There were 29 patients in normal and 22 patients in the low bicarbonate 
group. Bicarbonate level, total pancreatic juice volume (TPJV) and excretory flow rate (EFR) 
were recorded during IDST. Signal intensity ratio of pancreas (SIR), fat signal fraction (FSF), 
pancreatograms findings and grade of duodenal filling (DF) were recorded on S-MRCP by two 
blinded radiologists.  
RESULTS 
There was a significant difference in the signal intensity ratio of the pancreas to spleen (SIR p/s) 
between the normal and low bicarbonate groups (p<0.0001). A significant positive correlation 
was found between pancreatic fluid bicarbonate level and SIR p/s (p <0.0001).  SIR p/s of 1.2 
yielded sensitivity of 77% and specificity of 83% for detection of pancreatic exocrine 
dysfunction (AUC: 0.89).  
_________________________________________________________________________________
 
This is the author's manuscript of the article published in final edited form as: 
Tirkes, T., Fogel, E. L., Sherman, S., Lin, C., Swensson, J., Akisik, F., & Sandrasegaran, K. (2017). Detection of 
exocrine dysfunction by MRI in patients with early chronic pancreatitis. Abdominal Radiology, 42(2), 544–551. 
https://doi.org/10.1007/s00261-016-0917-2
CONCLUSION 
T1-weighted MR signal of the pancreas has a high sensitivity and specificity for the detection of 
parenchymal abnormalities related to exocrine dysfunction and can therefore be helpful in 
evaluation of suspected early CP. 
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INTRODUCTION 
The natural history of chronic pancreatitis is usually insidious. During the early stages of chronic 
pancreatitis (CP), the morphologic and functional changes are difficult to detect by conventional 
methods. [1-4].  Sensitivity of the practical non-invasive tests has been found to be inadequate 
[5] and ductal imaging can be normal in patients with early disease [5]. Therefore, establishing a 
diagnosis of CP at an early stage remains problematic [6-9]. Endoscopic ultrasound (EUS) 
findings can be used to predict the presence of pancreatic exocrine dysfunction in patients with 
chronic pancreatitis [10,11]. However, multicenter studies showed the interobserver agreement 
to be less than optimal using both the standard scoring and Rosemont classification [12]. Both 
ERCP and EUS can obtain biopsy samples however this is rarely pursued since biopsy itself can 
cause acute pancreatitis [13]. Therefore, validation of a widely available, less invasive imaging 
technique to detect early CP would have tremendous clinical benefits. Our objective was to 
assess the usefulness of T1-weighted signal changes in patients with suspected early CP. 
Specifically, we assessed whether the signal intensity ratio (SIR), can accurately differentiate 
individuals with and without pancreatic exocrine dysfunction when the pancreatic ductograms 
are normal.  
MATERIALS and METHODS 
Patient selection 
This retrospective study was approved by the Institutional Review Board (IRB) and a HIPAA 
compliant retrospective analysis was performed. Electronic medical records were searched from 
September 2006 to December 2014 to identify 258 patients who had undergone intraductal 
secretin stimulation test (IDST). All of the patients presented to the gastroenterology clinic with 
symptoms suspected to be of pancreatic origin and had an S-MRCP within 3 months of secretin 
stimulation test. This study excluded patients with an established diagnosis of acute or chronic 
pancreatitis (n=111), cystic fibrosis (n=2), pancreatic cystic neoplasm (n=61), pancreatic 
adenocarcinoma (n=27), hemochromatosis (n=1) and post splenectomy (n=3) and patients 
younger than 18 years old (n=2). Following applying the exclusion criteria, a total of 51 patients 
were eligible for the study. These patients were grouped into normal (n=29) or low bicarbonate 
group (n=22) based on bicarbonate concentration in the pancreatic juice. Seventy-nine percent of 
the patients in the normal group were female, versus 64% of patients in the low bicarbonate 
group. Mean age of the patients in the normal group was 43 (range 19-70) and in the low 
bicarbonate group it was 47 (range 32-65).  
Secretin Stimulation Test 
To make a diagnosis of chronic pancreatitis at the very early stages patients may require direct 
measurement of pancreatic exocrine function when the other diagnostic tests are normal or 
inconclusive. An endoscopic pancreatic function test (ePFT) shows promise for establishing a 
diagnosis of early CP, but its performance to date has typically been limited to tertiary referral 
centers. These tests may be performed at EGD, EUS or ERCP. Although there is discussion 
about which method is the better, IDST had gained popularity as a research tool and has been 
used as a reference standard to diagnose CP [14,15]. Gastroenterologists at our institution prefer 
the IDST; therefore this test was used in our study as the reference standard to establish the 
diagnosis of early CP. The technique of IDST involves cannulating the pancreatic duct during 
the ERCP. After an intravenous injection of 16 mcg of synthetic secretin (ChiRho Stim, 
ChiRhoClin Inc, Burtonsville, MD), pancreatic juice is collected in separate aliquots by 
continuous aspiration at 5-minute intervals for 30 minutes. The total pancreatic juice volume 
(TPJV), excretory flow rate (EFR) and highest concentration of bicarbonate for each of the 
aliquots is recorded.  Peak bicarbonate concentration of <105 mEq/L was used as indicator of 
decreased exocrine function [16-18].  
Imaging technique 
Patients fasted for at least four hours prior to the MR examination. S-MRCP was performed in 
all patients by acquiring images in either a 1.5 Tesla Magnetom Avanto scanner (n=35) or a 3.0 
Tesla Magnetom Verio scanner (n=16) (Siemens Medical Solutions, Erlangen, Germany). 
Region of interest (ROI) measurements for signal intensity ratio (SIR) were performed on axial 
pre-contrast, T1-weighted, fat-suppressed, volume interpolated 3D gradient echo sequence 
(VIBE, Siemens Medical Solutions, Malvern, PA, USA) using TR 5.01 ± 0.32 ms, TE 2.52 ms, 
12° flip angle, NEX 1, matrix 308 x 210 on 1.5T and TR 4.33 ± 0.32 ms, TE 1.47 ms, 9° flip 
angle, matrix 308 x 210 on 3.0T magnets. Same imaging parameters were used in all patients. 
ROI measurements for FSF were performed on axial breath-hold 2-point DIXON T1-weighted 
images using TR 7.47 ms, TE 4.76 ms, 10° flip angle, NEX 1, matrix 256 x 120 on 1.5 T and TR 
5.45 ms, TE 2.45 ms, 9° flip angle on 3.0T units. Approximately 16 μg of secretin was 
administered via slow intravenous infusion over one minute and subsequently the pancreas was 
imaged via a coronal 2D single shot turbo spin echo sequence (HASTE, Siemens Medical 
Solutions, Malvern, PA), repeated every 30 seconds for 10 minutes.   
Image analysis 
Two experienced radiologists who were blinded to the IDST findings, performed ROI signal 
intensity measurements from the head, body and tail of the pancreas, also spleen and paraspinal 
muscle as the reference organs, on unenhanced fat-suppressed T1-weighted images using picture 
archiving and communication system (Synapse, Fujifilm Medical Systems, Stamford, US). 
Special attention was given to making measurements using the same size (approximately 50 
mm2) circular/elliptical ROI in a homogenous region of the parenchyma avoiding volume 
averaging from the signal suppressed retroperitoneal fat, vessels and pancreatic duct. SIR was 
calculated by dividing the average pancreas signal intensity (SI) by the SI of the reference organ 
(spleen or muscle); SIR = SI Pancreas / SI Reference. Fat signal fraction (FSF) of the pancreas was 
calculated by measuring signal intensities at the same location as the T1-weigthed images on 
DIXON series using the formula FSF = SI Fat / [SI Fat + SI Water]. The largest diameter of the main 
pancreatic duct and number of ectatic side branches were recorded.  Duodenal filling (DF) was 
assessed on the last image of the post-secretin S-MRCP image as follows; grade 1, when the 
filling remained limited to the duodenal bulb; grade 2, when pancreatic juice filled the bulb and 
the duodenum up to the genu inferius; and grade 3, when the bulb and the duodenum were filled 
beyond the genu inferius. Grades 1 and 2 were considered decreased DF [14,19]. 
Statistical analysis 
Pearson's correlation coefficient was calculated to assess the correlation between bicarbonate 
concentration and SIR. Analyses of covariance (ANCOVA) models were used to determine the 
differences in SIR p/s between normal and decreased group as well as the variability of 
measurements between 1.5T and 3T scanners and signal intensities between head, body and tail 
of the pancreas. Logistic regression was used to find the cut-off SIR p/s between normal and 
decreased exocrine function group. The Student t-test with independent samples was used to 
determine differences of FSF, bicarbonate, EFR, and TPJV between the normal and low 
bicarbonate groups.  Spearman’s rank correlation coefficient was used to assess relationship 
between the bicarbonate level and SIR p/s or SIR p/m. The significance level (α) used in this study 
was < 0.05 and correlation coefficients were interpreted as: weak, 0.2; moderate, 0.5; strong, 0.8; 
and perfect 1.0 [20]. We used multiple regression model to analyze the relationship between a 
dependent variable (presence of low bicarbonate) and independent variables (SIR p/s, FSF, age, 
DF grade, IDST excretory rate and volume). Multiple regression model used automatic 
weighting to correct for heteroscedasticity and excluded independent variables from the model if 
the p value is higher than 0.2. Statistical analyses were performed using MedCalc version 16.8. 
(Medcalc, Mariakerke, Belgium). 
RESULTS 
The patients were categorized as normal or early CP based on peak pancreatic juice bicarbonate 
concentration (Table 1). There was no statistically significant difference between the age of two 
groups (p=0.18). T1-weighted SIR in the head, body and tail of the pancreas were statistically 
similar (p=0.87) therefore; average values were used in the analysis. Similar results were found 
on both the 1.5T and 3T scanners (p=0.62); therefore data from 1.5T and 3T were combined for 
each group.  
Reference Organ 
We compared the SIR of spleen (SIR p/s) and paraspinal muscle (SIR p/m) to determine which one 
is a better reference organ. Correlation of SIR p/m with bicarbonate level was less satisfactory 
(ρ=0.28, 95%CI: 0.01 - 0.52, p=0.04) compared to SIR p/s (ρ=0.70, 95%CI: 0.53-0.82, p<0.0001) 
as well as diagnostic performance (SIR p/m AUC=0.63, p=0.09 vs SIR p/s AUC=0.89, p 
=<0.0001). Therefore we used SIR p/s for further analysis.  
T1-weighted signal (Table 1) 
We found a strong positive correlation between pancreatic fluid bicarbonate level and SIR p/s (ρ= 
0.70, p <0.0001) as shown on Figure 1. Inter-observer correlation was excellent (kappa=0.90, p 
<0.0001).  There was a significant difference (p<0.0001) in the SIR p/s of the pancreas between 
the normal (mean 1.41, 95% CI: 1.31 - 1.51) and low bicarbonate group (mean 1.03, 95% CI: 
0.97 - 1.12) as shown on Figure 2-a. Receiver operating characteristic (ROC) curve with a 
pancreas to splenic SIR p/s threshold value of 1.2 yielded a sensitivity of 77% and specificity of 
83% for detection of exocrine dysfunction (AUC=0.89) (Figure 2-b).   
MR pancreatogram (Cambridge Classification)  
Within the normal group, S-MRCP showed 28 out of 29 pancreatograms to be normal/equivocal 
and only 1 was classified as mild CP according to the Cambridge classification. Within the early 
CP group, 20 out of 22 pancreatograms were classified as normal/equivocal according to 
Cambridge classification however diagnosed with early CP based on IDST results.  The ductal 
findings on remaining 2 patients were consisted with mild CP. Based on these results, S-MRCP 
using the Cambridge classification yielded sensitivity of 9% (95% CI: 1-29%), specificity of 
96% (95% CI: 82%-99%), positive predictive value of 67% (95% CI: 9-99%), negative 
predictive value of 58% (95% CI: 43-72%) for detection of early CP.   
Duodenal filling after secretin stimulation 
S-MRCP showed a statistically significant difference in the duodenal filling (DF) grade between 
the normal and low bicarbonate groups (p=0.03). Considering the DF grade 1 and 2 as abnormal; 
sensitivity, specificity, positive predictive value and negative predictive values were 55% (95% 
CI: 32-76%), 96% (95% CI: 82-99%), 92% (95% CI: 64-99%) and 74% (95% CI: 56-87%).  
Fat signal fraction 
In order to exclude the possibility that the relatively lower signal intensity of the pancreas was a 
result of partial volume effects from the voids left by signal-suppressed fat inter-digitating with 
parenchyma, pancreatic fat signal fraction (FSF) was calculated for both groups. Mean FSF of 
the normal group was 3.8% (95% CI: 3.0% - 4.7%) whereas mean of the low bicarbonate group 
was 4.6% (95% CI: 3.4% - 5.7%) and difference was not statistically significant (p=0.29) as 
depicted on Figure 3.  
IDST findings (Table 2) 
Two patients groups had significantly different excretory flow rate (EFR) (p= 0.01) and lower 
pancreatic juice volume (TPJV) (p= 0.0001). Mean EFR for normal group was 3.0 ml/min (95% 
CI: 2.5 - 3.5) and for the low bicarbonate group was 2.1 ml/min (95% CI: 1.7 - 2.6). Mean TPJV 
for the normal group was 54 mL (95% CI: 44 - 64) and for the low bicarbonate group was 30 mL 
(95% CI: 24 - 36).  
Multiple regression analysis was performed to show correlation between the prediction of low 
bicarbonate and other independent variables (SIR p/s, FSF, age, DF grade, IDST volume and 
rate).  SIR p/s was the only variable that showed statistically significant correlation with the low 
bicarbonate (p<0.0001) (Table 3).  
DISCUSSION   
The diagnosis of CP relies on relevant symptoms and diagnostic modalities to assess pancreatic 
structure and function [21].  Evaluation may range from a simple and straightforward task to a 
tremendously challenging and intensive investigative process. Several investigations reported 
that the signal intensity of normal pancreatic parenchyma on T1-weighted images is typically 
higher than in other organs, due to the short T1 relaxation time of normal pancreatic tissue [22]. 
This finding is best appreciated on unenhanced, fat suppressed, T1-weighted images [23-25]. 
The T1-weighted signal may be decreased in many forms of pathologies including acute and 
subacute pancreatitis in which the parenchyma becomes edematous; in chronic pancreatitis as the 
normal pancreatic parenchyma containing protein-rich cytoplasm becomes replaced by fibrosis 
and in hemochromatosis as the iron causes paramagnetic artifacts [22,25,26].  
In this study, pancreatic signal intensity was quantitatively measured in patients with upper 
abdominal pain suspected of pancreatic origin. These measurements were correlated with the 
results of a direct pancreatic function test. We found a strong positive correlation between the 
T1-weighted pancreatic signal and exocrine function. Our study was unique since the T1-
weighted signal of the pancreas was able to detect pancreatic exocrine dysfunction in patients 
with no ductal abnormalities (Figure 4). Future studies comparing healthy volunteers to 
suspected CP patients would be helpful.  
Among the prior reports [22,24-30], the most comparable study correlating the T1-weighted 
signal intensity of the pancreas with pancreatic function test was by Balci et.al. [28]. In that 
study, there was no T1 signal difference between normal and low bicarbonate groups, pancreatic 
juice was sampled from the duodenal lumen and there were only 12 patients in the decreased 
exocrine function group compared to 22 in our study. Using a larger patient population, we were 
able to demonstrate that T1-weighted MR signal can detect changes related to early CP with high 
sensitivity and specificity.  
Our results concur with the previously reported poor sensitivity of the Cambridge classification 
for the detection of early CP [5] based on ductography. In this study, ductal imaging did not 
identify early CP in 91% of patients; indicating that pancreatic exocrine function precedes the 
ductal changes in the disease process. Our results support the idea of developing a more 
comprehensive clinical diagnostic criteria for CP based on combination of clinical signs, 
pancreatic parenchymal changes and function [2].    
Large multi-centric clinical trials have shown that utilization of secretin during MRCP improves 
diagnosis and clinical decision making for patients with chronic pancreatitis [31]. S-MRCP can 
be used to measure the volume of fluid reserves in response to secretin stimulation, giving an 
estimate of exocrine function with a sensitivity of 72% and specificity of 87% [14,19]. Balci et al 
found a significant correlation between the decreased SIR and decreased DF by S-MRCP [27].  
Considering the DF grade 1 and 2 as abnormally low, we found a statistically significant 
difference between the two groups (p=0.03). Sensitivity and specificity of decreased DF for 
detection of exocrine dysfunction in our study population was 55% (12/22) and 96% (1/28) 
respectively. The reason for lower sensitivity of DF in our study can be explained by the fact that 
only early CP patients were included in the current study, while the former studies included all 
levels of severity of CP. Our results reiterate the low sensitivity of DF grade in diagnosis of early 
CP especially considering the limitations of this technique such as inability to suppress the fluid 
already present within the duodenum before secretin stimulation.   
The time and cost benefit of a diagnostic and quantitative metric such as T1-weighted signal can 
be significant compared to other MR imaging techniques of CP. T1-weighted gradient echo 
imaging of the pancreas takes only 1 breath hold (20 seconds) to obtain and is routinely acquired 
in almost every MR study. On the other hand, secretin significantly increases the cost of S-
MRCP, requires a slow intravenous injection and adds at least 12 minutes to the total 
examination time. For these reasons, secretin is not commonly used outside the tertiary imaging 
centers in the U.S. and did not become a mainstream imaging technique for CP.  
The present study is limited by the sample size. This was due to our strict patient selection 
criteria which lowered the number of patients. Another possible limitation in patient selection is 
that; according to some reports, secretin stimulation tests do not always predict pancreatic 
exocrine dysfunction in patients with CP [32,33]. Nevertheless, it is still considered one of the 
best direct pancreatic function tests, at least as a research tool.  
An important factor to consider when interpreting MR studies for CP is the presence of fatty 
infiltration and parenchymal atrophy. Since fat suppression is used for T1-weighted imaging, 
partial volume averaging of low signal of suppressed retroperitoneal fat inter-digitating with the 
pancreas could interfere with the MR signal. To control for this possibility, we ensured that the 
reviewers placed ROIs on relatively homogenous regions of the gland. We quantitatively 
measured the fat signal fraction in both groups using the chemical shift imaging technique. FSF 
in the mild CP group was higher, but not significantly different than the normal group (p=0.29).  
Clinical MR studies are performed in either 1.5 or 3 Tesla strength scanners and this 
investigation included both.  Theoretically speaking, T1-weighted properties of tissues vary with 
field strength and that is one of the reasons why we used signal intensity ratio, rather than the 
absolute signal of the pancreas alone. Statistical analysis of our data collected 1.5 and 3 Tesla 
yielded very similar results, and it is unlikely there would be discrepancies in our conclusions 
due to scanner field strength. It would also be helpful to verify our results on different MR 
vendors. 
In summary, this study demonstrated that there is a strong positive correlation between the 
pancreatic exocrine function and T1-weighted signal of the pancreas. T1-weighted signal 
intensity can be a clinically useful and relatively cost-effective test for detection of early chronic 
pancreatitis when the ductal imaging is normal.   
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Table 1. S-MRCP findings in the normal and low bicarbonate groups.   
Bicarbonate Level Normal  Low  p 
Cambridge Classification 
Normal/Equivocal 1 
Mild CP 2 
 
28 
20 
 
1 
2 
 
SIR p/s 1.41 (95% CI: 1.31-1.51) 
1.03 
(95% CI: 0.97-1.12) < 0.0001 
FSF 3.8% (95% CI: 3.0%-4.7%) 
4.6% 
(95% CI: 3.4%-5.7%) 0.29 
Duodenal Filling 
Grade 1 
Grade 2 
Grade 3 
 
0 
1 
28 
 
4 
8 
10 
0.03 
CP= Chronic pancreatitis, SIR p/s= Signal intensity ration of pancreas to spleen, FSF= Fat signal 
fraction of the pancreas. 
  
Table 2. IDST findings in the normal and low bicarbonate groups.   
 Normal  Low  p 
Bicarbonate 119 mEq/L (105-135) 90 mEq/L (68-105)  
TPJV 54 mL (44-64) 30 mL (24-36) 0.0001 
EFR 3.0 ml/min (2.5-3.5) 2.1 ml/min (1.7-2.6) 0.01 
TPJV: Total Pancreatic Juice Volume (mL), total amount collected during IDST 
EFR: Excretory Flow Rate determined during IDST, average rate 
Values in parenthesis are range. 
 
  
Table 3.  Multiple regression analysis of the independent variables in patients with low 
bicarbonate. 
Variables Coefficient Std. Error rpartial t p 
SIR p/s -0.4066 0.1648 -0.3896 -2.467 0.02 
FSF 1.9513 1.8413 0.1788 1.060 0.30 
IDST volume -0.0079 0.0049 -0.2652 -1.604 0.12 
IDST rate 0.09546 0.1108 0.1462 0.862 0.39 
DF 0.2637 0.1653 0.2640 1.596 0.12 
Age 0.0053 0.0038 0.2311 1.385 0.17 
SIR p/s=Signal intensity ratio of pancreas to spleen, FSF=Fat signal fraction of the pancreas, 
IDST=Intraductal secretin test, DF=duodenal filling grade. 
 
  
Figure Captions 
Fig. 1. Scatter plot of the pancreatic juice bicarbonate concentration and the SIR p/s of the 
pancreas to the spleen. There is strong positive correlation between the bicarbonate concentration 
and the T1-weighted signal of the pancreas (ρ= 0.70, p <0.0001). The horizontal dashed line is 
drawn at the bicarbonate concentration of 105 mEq/L. The vertical dashed line is drawn at the 
SIR p/s of 1.2 indicating our threshold value.  
 
Fig. 2-a. Box and whisker plot of SIR p/s for the normal and decreased bicarbonate group. There 
was a statistically significant difference between the normal and decreased exocrine function 
groups. The horizontal line was drawn at our threshold SIR p/s value of 1.2.  
 
Fig. 2-b. ROC curve plotted for threshold of 1.2 yielded a sensitivity of 77% and specificity of 
83% for detecting pancreatic exocrine dysfunction. 
 
Fig. 3. Box and whisker plot of the fat signal fraction (FSF) of the normal and decreased 
exocrine function group. Pancreatic fat fraction increased in the chronic pancreatitis group 
however this did not reach a statistically significant level in our study population (p=0.29).  
 
Fig. 4-a. 27-year-old female with history of Crohn’s disease currently in remission was referred 
to our institution following 2 weeks of unexplained epigastric and right upper quadrant 
abdominal pain. The patient was admitted to our gastroenterology service with suspicion of 
pancreatitis as the etiology. A coronal thick slab image from S-MRCP acquired 10 minutes after 
secretin injection shows a normal appearance of the pancreatic duct (thin arrows). The main 
pancreatic duct diameter was 2.1 mm and there were no ectatic side branches. Excreted 
pancreatic juice is seen as high T2 signal filling the duodenal lumen (thick arrows) beyond the 
2nd portion of the duodenum. With a negative S-MRCP result, sphincter of Oddi dysfunction was 
suspected as the etiology of the pain and subsequently ERCP was performed.  
 
Fig. 4-b. A fluoroscopic image obtained during ERCP following injection of contrast to the 
pancreatic duct, which shows no abnormalities (arrows). The sphincter pressure was within 
normal limits excluding possibility of sphincter of Oddi dysfunction. Following these negative 
findings, the gastroenterologist decided to proceed with IDST during the ERCP. Secretin was 
injected and pancreatic juice was collected directly from the pancreatic duct for up to 30 minutes. 
The peak bicarbonate concentration was 101 mEq/L and the mean EFR was 2.8 ml/min therefore 
the patient was deemed to have chronic pancreatitis. 
 
Fig. 4-c. Axial fat-suppressed unenhanced T1-weighted gradient echo MR image shows the tail 
of the pancreas (arrow) and the spleen. ROI measurements (circle ROIs) showed average signal 
intensity of 245 for the pancreas and 216 for the spleen. SIRp/s was 1.13.  
